Ann: Update on US Clinical Study-RAP.AX, page-36

The price will not hold once exposed in the U.S.
U.S. Hospitals are great at promoting the technologies to both staff and patients. This will then trigger media attention that then flows into major U.S. Investors..

To have even got this hospital to participate is bigger than you think. U.S. Health is a new beast compared to a little Brisbane hospital.

Adoption of anything left field in U.S. health is not a daily occurrence.. RAP will ether be taken over by a big U.S. player to secure the revenue of their existing products or our SP will see $1 plus prior to FDA.(IMO)

Also lets see what happens once management start doing the investment road shows in the U.S...